The therapeutic promises of Lianhuaqingke in the mice model of coronavirus pneumonia (HCoV-229E and SARS-CoV-2)

BACKGROUND: Lianhuaqingke (LHQK) has been approved for the treatment of acute tracheobronchitis and exerts a broad-spectrum antiviral effect in our previous study. METHODS: Acute pneumonia caused by HCoV-229E was modeled in BALB/c mice. The anti-viral effect of LHQK was assessed by measuring the lun...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mingye, Li, Wenyan, Cui, Wenwen, Hao, Yuanyuan, Mi, Yao, Wang, Hongtao, Hou, Yunlong, Jia, Zhenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521501/
https://www.ncbi.nlm.nih.gov/pubmed/34663385
http://dx.doi.org/10.1186/s13020-021-00513-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521501/
https://www.ncbi.nlm.nih.gov/pubmed/34663385
http://dx.doi.org/10.1186/s13020-021-00513-3

Ejemplares similares